REFOTDE is scaling its Phase I–III clinical research portfolio, with ongoing and upcoming trials targeting Neglected Tropical Diseases (NTDs), co-endemic infections, and environmentally mediated health risks. Our trials are conducted in alignment with international ethical, regulatory, and Good Clinical Practice (GCP) standards, with strong emphasis on participant safety, data integrity, and local research capacity strengthening.